Biocon's first-in-class anti-CD6 mAb reaches the market
- PMID: 24316625
- DOI: 10.1038/nbt1213-1062b
Biocon's first-in-class anti-CD6 mAb reaches the market
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous